Dmitrij Hristodorov

Dmitrij joined the Forbion team in 2020. Prior to joining Forbion, he was Senior Director of Global Business Development & Licensing at Bayer Pharma where he was mainly responsible for Ophthalmology, Cardiology, Nephrology and Pulmonology. Before joining the Business Development Group at Bayer Pharma, Dmitrij spent two years in preclinical R&D in Ophthalmology.